Granza Bio
PrivateLast Round
Seed
Jul 10, 2024
Total Funding Raised
$7.14M
Company Overview
Granza Bio is a biotechnology company that develops a cancer therapeutics platform aimed at assisting doctors in treating autoimmune diseases by specifically targeting cancer cells to minimize toxicity and side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Granza Bio Comparables
Compare Granza Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evox Therapeutics | 75% | |
| Entelexo Biotherapeutics | 69% | |
| FinalDose | 68% |
Granza Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2024 |
Granza Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| Pioneer Fund | Seed |
| Ritual Capital | Seed |
| Metaplanet Holdings | Seed |
| Ritual Capital | Seed |
| Zeno Ventures | Seed |
| Y Combinator | Seed |
Granza Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Granza Bio's valuation, stock price, and market status.
Is Granza Bio a public or private company?
Granza Bio is a private company.
What is the current stock price of Granza Bio?
Granza Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Granza Bio worth (valuation)?
Valuation information for Granza Bio is not publicly available.
Can I buy Granza Bio stock?
Granza Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Granza Bio's last funding round?
Granza Bio's most recent funding round was Seed on July 10, 2024.
Who are the main investors in Granza Bio?
Key investors in Granza Bio include Felicis Ventures.
Will Granza Bio IPO soon?
No public IPO plans have been announced for Granza Bio.
How can I track Granza Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Granza Bio's secondary market activity and sign up for updates.